| Primary |
| Hiv Infection |
75.6% |
| Antiretroviral Therapy |
8.0% |
| Prophylaxis |
3.4% |
| Lipodystrophy Acquired |
3.1% |
| Drug Resistance |
1.5% |
| Pneumonia |
1.5% |
| Pneumonia Aspiration |
1.1% |
| Hiv Test Positive |
0.8% |
| Human Immunodeficiency Virus Transmission |
0.8% |
| Hypersensitivity |
0.8% |
| Migraine |
0.8% |
| Acquired Immunodeficiency Syndrome |
0.4% |
| Arthralgia |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Chronic Hepatic Failure |
0.4% |
| Erectile Dysfunction |
0.4% |
| Prophylaxis Against Hiv Infection |
0.4% |
| Sinus Disorder |
0.4% |
|
| Nephrolithiasis |
13.6% |
| Pregnancy |
11.4% |
| Renal Failure Acute |
11.4% |
| Vomiting |
9.1% |
| Ventricular Tachycardia |
8.0% |
| Rhabdomyolysis |
5.7% |
| Malaise |
4.5% |
| Peripheral Vascular Disorder |
4.5% |
| Skin Hyperpigmentation |
4.5% |
| Blood Bilirubin Unconjugated Increased |
3.4% |
| Diabetes Mellitus |
3.4% |
| Calculus Ureteric |
2.3% |
| Drug Abuse |
2.3% |
| Gamma-glutamyltransferase Increased |
2.3% |
| Glucose Tolerance Test Abnormal |
2.3% |
| Jaundice |
2.3% |
| Kaposi's Sarcoma |
2.3% |
| Lipoma |
2.3% |
| Nephritis Interstitial |
2.3% |
| Pneumonia |
2.3% |
|
| Secondary |
| Hiv Infection |
52.8% |
| Drug Exposure During Pregnancy |
14.2% |
| Drug Use For Unknown Indication |
13.3% |
| Product Used For Unknown Indication |
3.6% |
| Antiretroviral Therapy |
2.4% |
| Acquired Immunodeficiency Syndrome |
1.6% |
| Antifungal Prophylaxis |
1.5% |
| Hepatitis C |
1.3% |
| Diffuse Panbronchiolitis |
1.3% |
| Systemic Antiviral Treatment |
1.1% |
| Prophylaxis |
1.1% |
| Maternal Exposure Timing Unspecified |
1.0% |
| Haemophilia |
0.8% |
| Hypertension |
0.8% |
| Retroviral Infection |
0.7% |
| Opportunistic Infection Prophylaxis |
0.6% |
| Generalised Anxiety Disorder |
0.5% |
| Hepatitis C Virus Test |
0.5% |
| Tuberculosis |
0.5% |
| Diabetes Mellitus |
0.4% |
|
| Drug Exposure During Pregnancy |
15.7% |
| Abortion Spontaneous |
9.6% |
| Premature Baby |
9.2% |
| Ultrasound Antenatal Screen Abnormal |
8.7% |
| White Blood Cell Count Decreased |
6.6% |
| Parkinsonism |
4.8% |
| Hyperglycaemia |
3.9% |
| Stillbirth |
3.9% |
| Thrombocytopenia |
3.9% |
| Ventricular Tachycardia |
3.5% |
| Vomiting |
3.5% |
| Hepatic Cirrhosis |
3.1% |
| Lymphoma |
3.1% |
| Nephrolithiasis |
3.1% |
| Pancreatitis |
3.1% |
| Rash |
3.1% |
| Sepsis |
3.1% |
| Weight Increased |
3.1% |
| Muscle Injury |
2.6% |
| Oesophageal Varices Haemorrhage |
2.6% |
|
| Concomitant |
| Hiv Infection |
56.9% |
| Drug Use For Unknown Indication |
21.0% |
| Product Used For Unknown Indication |
2.4% |
| Prophylaxis Against Hiv Infection |
2.4% |
| Acquired Immunodeficiency Syndrome |
2.1% |
| Hiv Test Positive |
1.8% |
| Antiretroviral Therapy |
1.7% |
| Antifungal Prophylaxis |
1.2% |
| Depression |
1.2% |
| Prophylaxis |
1.1% |
| Drug Hypersensitivity |
1.1% |
| Hypertension |
1.0% |
| Headache |
1.0% |
| Lymphoma Aids Related |
0.9% |
| Opportunistic Infection Prophylaxis |
0.9% |
| Hepatitis C |
0.8% |
| Insomnia |
0.7% |
| Castleman's Disease |
0.7% |
| Rash |
0.7% |
| Diabetes Mellitus |
0.6% |
|
| Vomiting |
13.0% |
| Abortion Spontaneous |
11.4% |
| Death |
8.1% |
| Premature Baby |
4.9% |
| Weight Decreased |
4.9% |
| Weight Increased |
4.9% |
| Acrochordon |
4.3% |
| Haemolytic Anaemia |
4.3% |
| Somnambulism |
4.3% |
| Transaminases Increased |
4.3% |
| Pyrexia |
3.8% |
| Renal Tubular Necrosis |
3.8% |
| Suicidal Ideation |
3.8% |
| Trisomy 21 |
3.8% |
| Ultrasound Antenatal Screen Abnormal |
3.8% |
| Visual Disturbance |
3.8% |
| Drug Exposure During Pregnancy |
3.2% |
| Hepatitis Acute |
3.2% |
| Peripheral Vascular Disorder |
3.2% |
| Renal Failure Acute |
3.2% |
|
| Interacting |
| Antiretroviral Therapy |
29.6% |
| Hiv Infection |
28.7% |
| Drug Use For Unknown Indication |
20.9% |
| Schizoaffective Disorder |
3.5% |
| Asthma |
2.6% |
| Drug Dependence |
2.6% |
| Liver Transplant |
2.6% |
| Atrial Fibrillation |
1.7% |
| Cholelithiasis |
1.7% |
| Hiv Wasting Syndrome |
1.7% |
| Ischaemic Cerebral Infarction |
1.7% |
| Abnormal Behaviour |
0.9% |
| Dyspepsia |
0.9% |
| Mental Disorder |
0.9% |
|
| Drug Interaction |
16.0% |
| Drug Resistance |
12.0% |
| Renal Failure |
12.0% |
| Drug Level Increased |
8.0% |
| Renal Failure Acute |
8.0% |
| Rhabdomyolysis |
8.0% |
| Kaposi's Sarcoma |
4.0% |
| Kaposi's Sarcoma Aids Related |
4.0% |
| Portal Vein Thrombosis |
4.0% |
| Rib Fracture |
4.0% |
| Sedation |
4.0% |
| Sepsis |
4.0% |
| Treatment Noncompliance |
4.0% |
| Viral Load Increased |
4.0% |
| Vomiting |
4.0% |
|
